Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036572 (
seizures
)
80,221
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Postictal values of plasma
prolactin
levels were measured in 15 children with generalized
seizures
, 8 children with pseudoseizures and 6 control subjects. In patients with generalized seizure, the mean plasma
prolactin
level was 28.6 +/- 2.3 ng/ml, whereas in patients with pseudoseizures and in controls, its mean values were 10.4 +/- 3.8 ng/ml and 9.8 +/- 2.6 ng/ml, respectively. Thus,
prolactin
levels were significantly (p < 0.001) elevated following generalized
seizures
but were almost normal following pseudoseizures. Plasma
prolactin
levels may, therefore, be helpful in differentiating between generalized
seizures
and pseudoseizures.
...
PMID:Plasma prolactin in epilepsy and pseudoseizures. 789 90
We studied serum
prolactin
levels after 24
seizures
occurring in eight subjects. Video-EEG intracranial monitoring confirmed temporal or frontal partial
seizures
.
Seizure
type, focus, and duration were similar for
seizures
with and without significant postictal
prolactin
elevations. The
seizure
-free interval (the time between
seizures
) varied considerably.
Seizures
occurring after longer
seizure
-free intervals (31.75 to 240 hours) showed robust
prolactin
responses. After shorter
seizure
-free intervals (1.07 to 25.42 hours),
prolactin
responses were reduced. This suggests that the amount of releasable
prolactin
is limited, depleted by
seizures
, or perhaps inhibited by
prolactin
feedback.
Seizure
-free intervals should be considered when interpreting
prolactin
levels.
...
PMID:Prolactin secretion following repetitive seizures. 789 94
This review discusses several aspects of epilepsy and sleep. The level of wakefulness is controlled by transmitters such as acetylcholine, norepinephrine, serotonin, and histamine. These neurotransmitters are involved in modulatory neurotransmission of the ascending brain stem systems, which play an important role in controlling the sleep-wake cycle. Experimental evidence suggests that rapid eye movement sleep atonia is induced by increased endogenous acetylcholine release. Regarding sleep factors, recent data suggest that
prolactin
may stimulate rapid eye movement sleep and that growth hormone-releasing factor is involved in non-rapid eye movement sleep regulation. The neuropharmacologic features of several animal models of epilepsy have been investigated. Epileptiform discharges of genetic absence
seizures
in rats have been found to be suppressed by cholinergic drugs. The beta-carboline abecarnil has a strong antiepileptic effect on spike-wave discharges in rats that generate spontaneous spike-wave discharges, and it may be useful as an antiepileptic drug. Sleep epilepsy has been studied in a model of amygdala-kindled kittens. During the postkindling development, multifocal epilepsy with convulsions occurred that were distributed throughout the sleep-wake cycle; this finding agrees with the clinical literature. A typical feature of juvenile myoclonic epilepsy is the occurrence of
seizures
in a strict relationship to the sleep-wake cycle. There is now some neurophysiologic evidence that this syndrome also causes disturbance of sleep stability with increased arousal reactions. Nocturnal paroxysmal dystonia is not a homogeneous entity. Several clinical reports indicate that the short-lasting variant is most likely a form of frontal lobe epilepsy, but the nature of the longer-lasting variants is still obscure.
...
PMID:Epilepsy and sleep. 791 13
Postictal serum
prolactin
and cortisol levels were estimated in 73 children having either epilepsy, febrile
seizures
, breath-holding spells, or fever without other manifestation and in 20 normal controls. Mean serum
prolactin
levels (28.6 +/- 2.3 ng/ml) were significantly higher (p < 0.001) in the epileptic group than in the group with febrile
seizures
(12.7 +/- 2.8 ng/ml), non-specific febrile illness (12.2 +/- 2.4 ng/ml), breath-holding spells (8.8 +/- 1.1 ng/ml) and normal controls (9.8 +/- 2.6 ng/ml). Mean serum cortisol levels were non-specifically elevated in children with epilepsy (32.8 +/- 2.2 ug/dl), febrile convulsion (34.2 +/- 4.1 ug/dl) and non-specific febril illness (30.6 +/- 2.4 ug/dl). Our observations suggest that elevated
prolactin
levels associated with afebrile epileptic
seizures
may help in differentiating epilepsy from febrile
seizures
and breath-holding spells. Cortisol levels appear to be non-specifically elevated in all stressful conditions.
...
PMID:Serum prolactin and cortisol in children with some paroxysmal disorders. 792 99
Sex steroid peripheral pattern, pulsatile luteinizing hormone (LH) secretion, gonadotropin and
prolactin
responses to LH-releasing hormone (LHRH) and thyrotropin-releasing hormone (TRH) were studied in 35 male epileptics treated with phenobarbital (PB), carbamazepine (CBZ), or phenytoin (PHT), and in age-matched healthy males. Idiopathic generalized epilepsy (IGE) was diagnosed in 12 cases and partial epilepsy (PE) in 23 cases. Patients were
seizure
-free and did not show EEG abnormalities at repeated controls in the last 5 years, so that interfering effects of
seizures
were possibly excluded. The aim of the study was to evaluate both the role of epileptic syndromes and of anti-epileptic drugs on the endocrine function. Changes in sex hormone binding globulin, total and free testosterone, dihydrotestosterone and delta 4-androstenedione were found to be independent of the epileptic syndrome type. The LH response to LHRH was lower in PB-treated PE than in IGE subjects on the same drug regimen. An impairment of LH pulsatility with respect to controls was found in PE but not in IGE patients taking PB. Among antiepileptic drugs, PHT is associated with higher sex hormone binding globulin and estradiol and lower free testosterone and dihydrotestosterone levels. PB and CBZ, but not PHT, blunt the LH response to exogenous LHRH in PE. Prolactin responses to TRH were consistently enhanced in PE subjects treated with CBZ or PHT.
...
PMID:Sex hormones, gonadotropins and prolactin in male epileptic subjects in remission: role of the epileptic syndrome and of antiepileptic drugs. 796 56
Determination of serum
prolactin
can help distinguish between epileptic and pseudo-epileptic attacks since generalized tonic-clonic and complex partial seizures frequently are accompanied by a transient rise in
prolactin
. In status epilepticus, however, serum
prolactin
levels are well within the normal range: cellular depletion due to the prolonged
seizure
activity has been suggested as a mechanism for this finding. The control of
prolactin
secretion is complex. Among several possible regulators, inhibitory dopamine and stimulatory thyrotropin-releasing hormone (TRH) may take part in the regulation of
prolactin
levels in connection with epileptic activity. There may be subpopulations of
prolactin
-producing cells that react differently in response to various regulators. A dopamine receptor blocker given during status epilepticus brings forth a distinct increase in
prolactin
levels. In order to add to the understanding of
prolactin
changes in connection with status epilepticus, we injected TRH i.v. during status epilepticus in seven consecutive patients. All patients had
prolactin
levels within the normal range (< 25 micrograms/l) before injection of TRH which resulted in at least a two-fold increase in
prolactin
levels. Our results contradict the hypothesis of cellular depletion of
prolactin
in connection with status epilepticus. The mechanism behind
prolactin
values within the normal range after prolonged
seizure
activity remains unknown.
Seizure
1993 Sep
PMID:Serum prolactin response to thyrotropin-releasing hormone during status epilepticus. 816 88
We measured postictal
prolactin
(
PRL
) levels during repetitive
seizures
in 14 patients (10 men and 4 women) suffering from epilepsy with focal and/or secondarily generalized
seizures
. Between two and six
seizures
occurred per patient (mean 2.7). The interveral between
seizures
was 15 min and 8 h 40 min (mean 3 h 32 min). Five of the 14 patients showed a marked postictal
PRL
rise after each
seizure
(i.e. concentrations above 700 microU/ml for women, 500 microU/ml for men). In the remaining 9 patients there was no detectable rise in
PRL
. A decrease in
PRL
did not occur in any of the 14 patients. In those patients who had shown a marked
PRL
increase after the first
seizure
, the
PRL
continued to rise in subsequent
seizures
. Unlike previous investigations, these results show that repetitive epileptic
seizures
are not necessarily followed by a decrease in postictal
PRL
levels. A decrease in
PRL
response is known to occur if there is progression to status epilepticus.
...
PMID:Serum prolactin response to repetitive epileptic seizures. 819 24
The predictivity of raised plasma
prolactin
(
PRL
) concentrations in differentiating
seizure
from syncopal attack was prospectively assessed in all patients consecutively admitted to the Clinica Neurologica of Brescia, Italy in a 12-month period who fulfilled the criteria for either a
seizure
or syncopal attack. Postictal plasma
prolactin
concentration (P1) was assessed as soon as possible after the event. Three further assessments were performed: P2 was sampled 1 h after P1, P3, and P4 were sampled in the morning for the next 2 days. Patients who had had a
seizure
showed significantly increased P1 concentrations, when P1 was sampled within 60 min of the attack. In
seizure
patients assessed > 1 h after the event, P1 was not significantly different from either P2, P3, or P4. In patients who had had a syncopal attack,
PRL
concentration never increased. In patients assessed < or = 60 min after the
seizure
, cutoff criterion of P1 exceeding by +3 SD the mean calculated on P2, P3, and P4 yielded a positive predictive value of 89% and a negative predictive value of 61%. These findings confirm that plasma
prolactin
concentration is highly predictive of true epilepsy but barely predictive of pseudoseizures.
...
PMID:Predictivity of plasma prolactin levels in differentiating epilepsy from pseudoseizures: a prospective study. 824 55
In 95 patients (44 women and 51 men, aged 14 to 86 yrs., average 44.9 yrs.) the serum levels of
prolactin
, cortisol and uric acid were investigated 30, 60 and 120 min after
seizure
-like events. There were 53 fits of epileptic aetiology (EE), mainly tonic-clonic, and 42 attacks of non-epileptic aetiology (NEE). The uric acid of the epileptic patients 30 min postictally revealed significantly higher ratings (p < 0.05) compared to the control group (n = 36), but not compared to the NEE group. Serum cortisol was significantly higher after all investigated disturbances without differences in the EE and NEE group. After epileptic and non-epileptic attacks
prolactin
was significantly (p < 0.05) elevated in comparison to the baseline. The increase of 3 times the amount of the individual baseline and at the same time exceeding the range of reference were found in 73% of the epileptic and only in 7% of the non-epileptic patients. As hypothesis to the postictal
prolactin
rise we discuss disturbances in the neurotransmitter equilibrium within the hypothalamic-hypophyseal axis. We regard
prolactin
as a biochemical marker, which is a valuable aid in the differential diagnosis of epileptic and non-epileptic fits.
...
PMID:[Correlation of serum prolactin and cortisol values with paroxysmal disorders of epileptic and non-epileptic origin and their clinical value]. 827 Feb 26
Calcification is a well recognized but relatively uncommon feature of
prolactin
-secreting, growth hormone-secreting and non-functional pituitary tumours. It varies in extent, but rarely exceeds a tiny amount histologically or radiologically. Thyrotroph adenomas are the rarest of the secretory pituitary tumours, accounting for less than 1% of cases, and partial calcification of such lesions has been reported in only three cases. We describe two patients in whom the clinical and biochemical features indicated the presence of a TSH-secreting adenoma and radiology demonstrated a large 'pituitary stone'. One patient, a 59-year-old female, initially presented with hyperthyroidism, aged 18, and was rendered euthyroid by two subtotal thyroidectomies before a pituitary lesion was suspected, over 20 years later. Autonomous secretion of thyrotrophin was demonstrated by dynamic tests, and the failure of exogenous T3 to reduce the serum TSH. In the absence of tumour expansion and compressive symptoms, pituitary surgery was not undertaken. At the age of 56, she developed symptoms of intermittent ataxia and diplopia, culminating in a focal
seizure
, and was found on CT scan to have, in addition to the pituitary lesion, a parasagittal meningioma. This was successfully removed at craniotomy. In the second patient, a 42-year-old male, the finding of hyperthyroidism in association with an elevated TSH concentration led to the discovery of a pituitary stone which was removed transethmoidally, together with surrounding adenomatous tissue which stained positively for TSH on immunocytochemistry.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Pituitary stone: two cases of densely calcified thyrotrophin-secreting pituitary adenomas. 830 73
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>